| Features | |
| Active substance | Nifedipine |
| Also known as | Adalat |
| Blood pressure | Reduces systolic and diastolic blood pressure |
| Chemical name | Dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate |
| Dosage (medical) | Typically 10 to 60 mg daily in divided doses for hypertension and angina |
| Dosage (sports) | Not applicable |
| Effects | Reduction in arterial pressure, increased oxygen delivery to the myocardium |
| Formula | C17H18N2O6 |
| Half-life | 2 to 5 hours |
| Hepatotoxicity | Low risk |
| Lab Test | Not specific for monitoring nifedipine |
| Main action | Lowers blood pressure by relaxing blood vessels and decreasing heart workload |
| Side effects | Headache, flushing, dizziness, peripheral edema, palpitations |
| Storage conditions | Store at room temperature, protect from light and moisture |
| Strength | 30mg |
| Substance class | Calcium channel blocker |
| Trade name | Adalat, Procardia |
| Use in sports | Not typically used in sports |
| Water Retention | Minimal |
| Manufacturer | J.B. Chemicals & Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |